Cemindo Gemilang Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Cemindo Gemilang Tbk. trades at Rp790 (market cap 13.53T, 18.83M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 14.59M 24h volume). The key difference: Cemindo Gemilang Tbk. is far larger — about 28.8× Prodia Diagnostic Line Tbk's market cap, and Cemindo Gemilang Tbk. is more actively traded (18.83M versus 14.59M). Which is the better fit depends on your goals.
| CMNT | PRDL | |
|---|---|---|
Market Cap | 13.53T | 470.58B |
Volume | 18.83M | 14.59M |
Lot | 188.3K | 145.93K |
Turnover | 14.85B | 3.84B |
Average Price | 788.52 | 263.18 |
Value | 14.85B | 3.84B |
Indicative Equilibrium Price | 800 | 272 |
Indicative Equilibrium Volume | 1 | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cemindo Gemilang Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 9 of Humberg Lie, S.H., S.E., M.Kn, dated July 4, 2011.
Read more on CMNT →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →